The Evolving Endovascular Therapy Toolkit: Real-World and Clinical Experiences with Pipeline Flex and Vantage with Shield Technology and Solitaire X 3 mm
Article Information
Volume 7 Issue 2 January 2022, pages 53-59
Received 10th January 2022; Accepted 12th January 2022
Istvan Szikora – National Institute of Mental Health, Neurology and Neurosurgery, Semmelweis University Medical School, Budapest, Hungary
Riitta Rautio – Department of Interventional Radiology, Turku University Hospital, Finland
Adnan Siddiqui – Department of Neurosurgery, Canon Stroke and Vascular Research Center, SUNY University, Buffalo, United States.
Abstract:
Drs Szikora and Rautio presented their experiences with new flow diverters at a Symposium Sponsored by Medtronic that took place on Thursday, 9th September 2021 and was part of the 13th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT), in Nice, France. Dr Szikora presented the analysis of the first 400-patient cohort treated with the Pipeline Flex with Shield technology from the INSPIRE registry. Dr Rautio shared her clinical experience with Pipeline Vantage with Shield technology through case studies. Dr Siddiqui presented his preliminary clinical experience with the next generation of Solitaire X, the smallest diameter revascularisation device made with the ability to deploy in smaller blood vessels.
Keywords:
FLOW DIVERTER, PIPELINE FLEX, PIPELINE VANTAGE, REVASCULARISATION DEVICE, SOLITAIRE XFollow Us
Newsletter
Keep up to date with our latest
articles and journals
0 Comments